Versions Compared
Key
- This line was added.
- This line was removed.
- Formatting was changed.
Procedure:
| Expand | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||||||||||||||||
The plate map is as follows. Using lipo3k protocol. There will be two plates using this platemap, one with suspended transfection and one with adherent transfection.
|
Results:
Discussion:
Progress:
| Cloning | Transfection | Dox | Cytometry | Data Analysis | ||
|---|---|---|---|---|---|---|
| 07/06 | 07/07 | 07/08 |
Background:
Because transfecting a large number of plasmids (~8) into HEK293 cells can drastically increase cytotoxicity and lower transfection efficiency, we are optimizing our transfections before we start characterizing the B-Cell Receptor. We plan on evaluating suspended vs. adherent transfection and varying total mass of DNA transfected. Because we will be transfecting a large protein complex (BCR) into our cells we want to use many different plasmids interacting to test our transfection efficiency.
Approach:
We will be testing in duplicate 10, 25, 50,100, 250, 500, and 1000ng of DNA with lipo 3K suspended vs non suspended transfection to determine optimal transfection conditions for our cells.
Parts Needed:
| Part | Status | |
|---|---|---|
| hEF1a:rtTa | ||
| TRE:Gal4VP16 | ||
| UAS:mKate | ||
| hEF1a:eYFP | ||
| hEF1a:eBFP |
Results:
Discussion: